Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus.
In a previous study, progesterone treatment of female monkeys immunized with live, attenuated SHIV89.6 abrogated the generally consistent protection from vaginal simian immunodeficiency virus (SIV) challenge. The mechanisms responsible for the loss of protection remain to be defined. The objective o...
Main Authors: | Meritxell Genescà, Michael B McChesney, Christopher J Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-03-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2843738?pdf=render |
Similar Items
-
Incidental Finding of Persistent Hydatidiform Mole in an Adolescent on Depo-Provera
by: Olukayode Akinlaja, et al.
Published: (2016-01-01) -
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
by: Lam C, et al.
Published: (2016-09-01) -
The Effect of Long Term Use of Combined Pills and Depo-Provera on Bone Density Parameters
by: Wafa Al- Omari, et al.
Published: (2010-01-01) -
Women's experiences of amenorrhea following Depo-Provera use at a district hospital in Malawi
by: Mwafulirwa, Boss
Published: (2016) -
Opyt primeneniya preparata depo-provera u zhenshchin pozdnego reproduktivnogo vozrasta s fibrozno-kistoznoy mastopatiey
by: T T Tagieva
Published: (2000-08-01)